Novel improved version of the vaccine developed for meningitis and bloodstream infections, which are caused by 'meningococcal group B' bacteria will allow immunization of younger kids and addresses several limitations of the current vaccinations.
from Medindia Health News https://ift.tt/2LzHm1B
No comments:
Post a Comment